ProCE Banner Activity

Switching ART in a Virologically Suppressed Person With Suspected Underlying Resistance

Podcast Episodes
Listen to Timothy J. Wilkin, MD, MPH, provide a case-based overview of switching antiretroviral therapy in a person with viral suppression on their current regimen who has a history of virologic failure with drug-resistance mutations.

Released: October 20, 2022

Expiration: October 19, 2023

Share

Faculty

Timothy Wilkin

Timothy Wilkin, MD, MPH

Assistant Professor of Medicine
Division of Infectious Diseases
Weill Medical College of Cornell University
New York, New York

Provided by

Jointly provided by the Association of Nurses in AIDS Care and Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

ViiV Healthcare

Faculty Disclosure

Primary Author

Timothy Wilkin, MD, MPH

Assistant Professor of Medicine
Division of Infectious Diseases
Weill Medical College of Cornell University
New York, New York

Timothy J. Wilkin, MD, MPH: consultant: Merck; researcher: GlaxoSmithKline/ViiV Healthcare, Merck.